The Journal of Bone and Joint Surgery (American) 84:921-929 (2002)
© 2002 The Journal of Bone and Joint Surgery, Inc.
Treatment of Active Unicameral Bone Cysts with Percutaneous Injection of Demineralized Bone Matrix and Autogenous Bone Marrow
Bruce T. Rougraff, MD and
Thomas J. Kling, MD
Investigation performed at Orthopaedics Indianapolis, Indianapolis,
Indiana
Bruce T. Rougraff, MD
Thomas J. Kling, MD
Orthopaedics Indianapolis, 8450 Northwest Boulevard, Indianapolis,
IN 46278
No benefits in any form have been received or will be received from
a commerical party related directly or indirectly to the subject
of this article. No funds were received in support of this study.
A commentary is available with the electronic versions of this article,
on our web site (www.jbjs.org) and on our quarterly CD-ROM (call
our subscription department, at 781-449-9780, to order the CD-ROM).
Background:
The treatment of unicameral bone cysts varies from open bone-grafting
procedures to percutaneous injection of corticosteroids or bone
marrow. The purpose of this study was to evaluate the feasibility
and effectiveness of percutaneous injection of a mixture of demineralized
bone matrix and autogenous bone marrow for the treatment of simple
bone cysts.
Methods:
Twenty-three patients with an active unicameral bone cyst were
treated with trephination and injection of allogeneic demineralized
bone matrix and autogenous bone marrow. The patients were followed
for an average of fifty months (range, thirty to eighty-one months),
at which time pain, function, and radiographic signs of resolution
of the cyst were assessed.
Results:
The average time until the patients had pain relief was five weeks,
and the average time until the patients returned to full, unrestricted
activities was six weeks. Bone-healing at the site of the injection
was first seen radiographically at three to six months. No patient
had a pathologic fracture during this early bone-healing stage.
Cortical remodeling was seen radiographically by six to nine months,
and after one year the response was usually complete, changing very
little from then on. Five patients required a second injection because
of recurrence of the cyst, and all five had a clinically and radiographically
quiescent cyst after an average of thirty-six additional months
of follow-up. Seven of the twenty-three patients had incomplete healing
manifested by small, persistent radiolucent areas within the original
cyst. None of these cysts increased in size or resulted in pain
or fracture.
Conclusions:
Percutaneous injection of allogeneic demineralized bone matrix
and autogenous bone marrow is an effective treatment for unicameral
bone cysts.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Carpenter and T. Motley
Bone Matrix Therapy for Aneurysmal Bone Cysts
J Am Podiatr Med Assoc,
July 1, 2005;
95(4):
394 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Kocher and J. F. Sarwark
What's New in Pediatric Orthopaedics
J. Bone Joint Surg. Am.,
June 1, 2004;
86(6):
1337 - 1346.
[Full Text]
[PDF]
|
 |
|
|